Index
S&P 500
Market Cap
11.79B
Enterprise Value
26.25B
Income
895.08M
Sales
14.17B
Book/sh
-9.32
Cash/sh
10.33
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
78000
IPO
Oct 31, 1995
P/E
14.18
Forward P/E
11.22
PEG
0.51
P/S
0.83
P/B
-
P/C
18.15
P/FCF
9.11
EV/EBITDA
9.22
EV/Sales
1.85
Quick Ratio
1.36
Current Ratio
1.41
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
13.22
EPS next Y
16.71
EPS next Q
4.26
EPS this Y
36.17%
EPS next Y
13.82%
EPS next 5Y
21.92%
EPS past 3/5Y
18.56% 8.29%
Sales past 3/5Y
5.53% 3.39%
EPS Y/Y TTM
36.05%
Sales Y/Y TTM
6.38%
EPS Q/Q
67.00%
Sales Q/Q
4.62%
Insider Own
2.08%
Insider Trans
-59.97%
Inst Own
92.71%
Inst Trans
-3.36%
ROA
5.06%
ROE
-
ROIC
7.31%
Gross Margin
27.35%
Oper. Margin
15.17%
Profit Margin
6.32%
SMA20
2.67%
SMA50
3.36%
SMA200
5.92%
Trades
Shs Outstand
63.40M
Shs Float
61.59M
52W High
247.49 -24.24%
52W Low
101.00 85.64%
Volatility
4.83% 3.45%
ATR (14)
7.29
RSI (14)
54.33
Beta
0.88
Rel Volume
2.20
Avg Volume
801.52K
Volume
1,760,644
Perf Week
2.10%
Perf Month
6.32%
Perf Quarter
-19.76%
Perf Half Y
23.64%
Perf YTD
65.04%
Perf Year
57.89%
Perf 3Y
144.65%
Perf 5Y
81.62%
Perf 10Y
239.92%
Prev Close
193.31
Price
187.50
Change %
-3.01%
Analysts 11 incl. previous ratings
Rating Distribution 4 Buy · 6 Hold · 1 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Aug 07, 2026 Upgrade T TD Cowen
Hold → Buy $220 +17.3% May 06, 2026 Upgrade D Deutsche Bank
Hold → Buy $220 +17.3% Mar 06, 2024 Initiated B Barclays
Equal Weight $133 -29.1% Aug 07, 2023 Upgrade U UBS
Neutral → Buy $100 → $142 -24.3% Nov 01, 2022 Downgrade D Deutsche Bank
Buy → Hold $97 → $72 -61.6% Oct 31, 2022 Downgrade U UBS
Buy → Neutral $117 → $74 -60.5% Aug 19, 2022 Resumed U UBS
Buy $106 → $117 -37.6% Jun 21, 2022 Reiterated B BofA Securities
Underperform $110 → $90 -52.0% Sep 10, 2021 Initiated C Cowen
Market Perform $145 -22.7% Aug 12, 2021 Downgrade B Barclays
Overweight → Equal Weight $135 → $146 -22.1% Mar 26, 2021 Downgrade B BofA Securities
Neutral → Underperform $127 → $118 -37.1% Jan 05, 2021 Downgrade B BofA Securities
Buy → Neutral $127 -32.3% Jan 24, 2020 Upgrade G Goldman
Neutral → Buy $72 → $97 -48.3% Nov 07, 2019 Downgrade R Raymond James
Outperform → Mkt Perform Oct 25, 2019 Downgrade W Wolfe Research
Outperform → Peer Perform Sep 11, 2019 Downgrade W William Blair
Outperform → Mkt Perform Jul 26, 2019 Downgrade R Robert W. Baird
Outperform → Neutral $70 → $65 -65.3% Jan 08, 2019 Upgrade U UBS
Sell → Neutral Jan 03, 2019 Initiated D Deutsche Bank
Buy $60 -68.0% Dec 14, 2018 Initiated B Barclays
Overweight
Show Previous Ratings
Oct-30-26 03:51PM
Oct-29-26 07:08PM
(Earnings Whispers)
+5.10%
04:05PM
Oct-27-26 09:00AM
Oct-26-26 10:10AM
06:57PM
Loading…
Oct-21-26 06:57PM
(Earnings Whispers)
+5.25%
Oct-20-26 07:23PM
04:30PM
Oct-19-26 05:37PM
Oct-15-26 09:00AM
Oct-08-26 04:00PM
Sep-24-26 04:30PM
Sep-17-26 04:30PM
Sep-14-26 09:40AM
Sep-08-26 09:35AM
07:23AM
Loading…
Sep-02-26 07:23AM
Aug-26-26 06:47AM
Aug-25-26 07:07AM
06:00AM
Aug-14-26 05:29PM
Aug-12-26 10:45AM
Aug-07-26 06:34AM
Aug-05-26 04:30PM
01:03AM
Aug-04-26 04:05PM
Jul-21-26 05:00PM
May-18-26 03:00PM
May-12-26 10:41AM
May-06-26 06:01PM
May-05-26 04:05PM
02:06PM
Loading…
Apr-20-26 02:06PM
Mar-31-26 08:06PM
Mar-18-26 03:00PM
Mar-06-26 11:49AM
Mar-05-26 12:40PM
Mar-04-26 11:30AM
10:08AM
Mar-03-26 06:56PM
Feb-27-26 04:48AM
04:03AM
03:50AM
Feb-24-26 02:00PM
09:40AM
02:53AM
Feb-23-26 09:40AM
Feb-20-26 09:50AM
04:09AM
Feb-19-26 09:20AM
05:30AM
04:34AM
Feb-17-26 04:53PM
Feb-13-26 10:24AM
Feb-12-26 11:03AM
10:54AM
10:41AM
09:25AM
Feb-11-26 09:15AM
Feb-10-26 12:30PM
09:32AM
Feb-09-26 10:38AM
08:50AM
12:31AM
Feb-05-26 09:40AM
09:40AM
Feb-04-26 07:55PM
(Morningstar Research)
+5.44%
02:54PM
10:59AM
Feb-03-26 06:03PM
(The Wall Street Journal)
+21.17%
04:26PM
01:18PM
12:38PM
12:25PM
11:45AM
11:16AM
11:14AM
10:23AM
09:59AM
09:40AM
(The Wall Street Journal)
08:10AM
05:54AM
12:01AM
Feb-02-26 09:55PM
08:40PM
06:38PM
05:20PM
04:20PM
04:05PM
03:00PM
Jan-31-26 10:01PM
Jan-30-26 11:56AM
Jan-29-26 11:34PM
Jan-27-26 06:00PM
Jan-21-26 06:15PM
10:00AM
Jan-19-26 12:31PM
Jan-16-26 01:56PM
04:25AM
Jan-15-26 10:34AM
Jan-14-26 11:50AM
Jan-13-26 06:00PM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BERKSHIRE HATHAWAY INC 10% Owner Oct 27 '26 Sale 180.43 382,563 69,026,033 28,314,666 Oct 29 05:21 PM BERKSHIRE HATHAWAY INC 10% Owner Jul 31 '26 Sale 199.55 182,980 36,513,293 28,697,229 Aug 04 05:27 PM Waters Kathleen Alyce Chief Legal & Pub. Affairs Off Jun 15 '26 Sale 208.40 15,405 3,210,377 109,194 Jun 17 06:10 PM Rodriguez Javier Chief Executive Officer Jun 16 '26 Sale 209.28 39,407 8,247,018 840,408 Jun 17 06:09 PM Rodriguez Javier Chief Executive Officer Jun 15 '26 Sale 209.50 30,000 6,285,090 879,815 Jun 17 06:09 PM Javier Rodgriguez Officer Jun 16 '26 Proposed Sale 209.28 39,407 8,247,016 Jun 16 04:44 PM Kathleen Waters Officer Jun 15 '26 Proposed Sale 207.84 8,950 1,860,202 Jun 15 04:53 PM Javier Rodriguez Officer Jun 15 '26 Proposed Sale 209.50 30,000 6,285,102 Jun 15 04:48 PM Waters Kathleen Alyce Officer Jun 15 '26 Proposed Sale 207.93 6,455 1,342,188 Jun 15 04:10 PM HEARTY JAMES O Chief Compliance Officer May 14 '26 Option Exercise 110.63 5,784 639,884 41,737 May 18 04:08 PM HEARTY JAMES O Chief Compliance Officer May 15 '26 Sale 193.98 15,000 2,909,745 22,389 May 18 04:08 PM James Hearty Officer May 15 '26 Proposed Sale 193.93 15,000 2,908,950 May 15 03:12 PM Maughan David Paul Chief Operating Officer, DKC May 12 '26 Sale 199.25 13,456 2,681,162 94,105 May 13 04:10 PM Maughan David Paul Chief Operating Officer, DKC May 11 '26 Sale 199.15 7,073 1,408,581 107,561 May 13 04:10 PM David Maughan Officer May 11 '26 Proposed Sale 198.03 20,529 4,065,340 May 11 05:40 PM ACKERMAN JOEL CFO and Treasurer May 07 '26 Sale 192.10 51,471 9,887,528 132,434 May 11 04:05 PM HEARTY JAMES O Chief Compliance Officer May 06 '26 Sale 174.87 2,184 381,916 35,953 May 08 04:04 PM Joel Ackerman Officer May 07 '26 Proposed Sale 191.50 51,471 9,856,696 May 07 04:43 PM HEARTY JAMES O Officer May 06 '26 Proposed Sale 169.28 2,184 369,708 May 06 04:03 PM BERKSHIRE HATHAWAY INC 10% Owner May 01 '26 Sale 149.84 1,220,376 182,864,679 28,880,209 May 05 06:52 PM Waters Kathleen Alyce Chief Legal & Pub. Affairs Off Feb 06 '26 Option Exercise 108.93 8,079 880,045 105,833 Feb 09 06:57 PM ACKERMAN JOEL CFO and Treasuer Feb 06 '26 Option Exercise 108.93 44,065 4,800,000 185,705 Feb 09 06:56 PM BERKSHIRE HATHAWAY INC 10% Owner Jan 29 '26 Sale 120.56 1,658,480 199,939,881 30,100,585 Feb 02 05:30 PM HEARTY JAMES O Chief Compliance Officer Dec 04 '25 Option Exercise 108.93 5,875 639,964 31,913 Dec 05 04:35 PM
DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
CEO & Executive Director Mr. Javier J. Rodriguez
CFO & Treasurer Mr. Joel Ackerman
Chief Legal & Public Affairs Officer Ms. Kathleen Alyce Waters
Chief Compliance Officer Mr. James O. Hearty
Chief Operating Officer of DaVita Kidney Care Mr. David P. Maughan